ArticleCell communication and signaling : CCS2026
Trophoblast derived extracellular vesicles trigger secondary vesicle release from endometrial epithelial cells.
Article in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Extracellular vesicles (EVs) are emerging mediators of cellular communication, carrying bioactive molecules that can alter the function of recipient cells. Yet, how these signals are recognized and interpreted by recipient cells remains unclear. For communication to be effective, signals must reach the right cells at the right time, suggesting that EVs likely target specific cells, an aspect often overlooked in mechanistic studies.In this study, we used an in vitro embryo implantation model consisting of JAr (trophoblast) and RL95-2 (endometrial) cells to explore targeted communication in a physiologically relevant context. Our previous findings showed that JAr-derived EVs specifically induce rapid secretion of milk fat globule epidermal growth factor-8 (MFGE8) from RL95-2 cells. Using MFGE8 as a functional readout, we further investigated the underlying mechanisms of EV mediated targeted cell communication.We found that RL95-2 responses to JAr EVs depend on clathrin-mediated endocytosis and endosomal acidification. Moreover, Rab27a-dependent secondary vesicle release contributed to increased MFGE8 secretion in endometrial cells. Importantly, optimal EV activity required precise pairing between EVs and recipient cells, indicating that EV-triggered vesicle release is not merely a recycling process. Finally, recipient cell stress disrupted vesicle release and impaired responses to EV signals. By combining this in vitro model with MFGE8 as a rapid functional readout, we highlight a natural mechanism of targeted EV communication.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.